ストックスクリーナーアプリを入手
1.11
29.75%
0.2545
プレマーケット:
1.11
前日終値:
$0.8555
開ける：
$0.9328
24時間の取引高:
1.06M
Relative Volume:
1.33
時価総額：
$99.17M
収益：
-
当期純損益:
$-166.14M
株価収益率:
-0.5781
EPS:
-1.92
ネットキャッシュフロー:
$-139.92M
1週間 パフォーマンス:
+25.91%
1か月 パフォーマンス:
-7.50%
6か月 パフォーマンス:
+61.06%
1年 パフォーマンス:
-4.31%
1日の値動き範囲:
$0.9299
$1.15
1週間の範囲:
$0.8099
$1.15
52週間の値動き範囲:
$0.535
$1.69
Allakos Inc Stock (ALLK) Company Profile
ALLK を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ALLK
Allakos Inc
|
1.11 | 99.17M | 0 | -166.14M | -139.92M | -1.92 |
|
VRTX
Vertex Pharmaceuticals Inc
|
427.89 | 110.19B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
687.80 | 75.58B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
647.39 | 38.71B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
264.99 | 34.18B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
117.25 | 28.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Allakos Inc Stock (ALLK) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-01-17 | ダウングレード | Jefferies | Buy → Hold |
| 2024-01-16 | ダウングレード | Cantor Fitzgerald | Overweight → Neutral |
| 2023-12-18 | アップグレード | William Blair | Mkt Perform → Outperform |
| 2023-12-08 | 再開されました | Jefferies | Buy |
| 2023-09-27 | 開始されました | JMP Securities | Mkt Outperform |
| 2023-05-12 | アップグレード | Jefferies | Hold → Buy |
| 2023-03-07 | 開始されました | Piper Sandler | Overweight |
| 2022-09-12 | ダウングレード | SMBC Nikko | Neutral → Underperform |
| 2021-12-22 | ダウングレード | BofA Securities | Buy → Underperform |
| 2021-12-22 | ダウングレード | Cowen | Outperform → Market Perform |
| 2021-12-22 | ダウングレード | Jefferies | Buy → Hold |
| 2021-12-22 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
| 2021-12-22 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2021-08-26 | 開始されました | Morgan Stanley | Equal-Weight |
| 2021-07-15 | 開始されました | Cowen | Outperform |
| 2021-05-18 | 開始されました | H.C. Wainwright | Buy |
| 2021-02-24 | 開始されました | Cantor Fitzgerald | Overweight |
| 2021-01-15 | 開始されました | BofA Securities | Buy |
| 2020-12-21 | 開始されました | SVB Leerink | Outperform |
| 2020-02-27 | 開始されました | Barclays | Underweight |
| 2020-02-04 | 再開されました | Goldman | Neutral |
| 2018-08-13 | 開始されました | Goldman | Neutral |
| 2018-08-13 | 開始されました | Jefferies | Buy |
| 2018-08-13 | 開始されました | William Blair | Outperform |
すべてを表示
Allakos Inc (ALLK) 最新ニュース
Allakos Inc. (NASDAQ:ALLK) Shares Sold by Barclays PLC - Defense World
Jane Street Group LLC Has $34,000 Stake in Allakos Inc. (NASDAQ:ALLK) - Defense World
Atopic Dermatitis Clinical and Non-Clinical Studies, Key - openPR
BIOTECH MARKET RESEARCH $ALLK | Ep. 550 - substack.com
Geode Capital Management LLC Purchases 80,763 Shares of Allakos Inc. (NASDAQ:ALLK) - Defense World
Institutional owners may take dramatic actions as Allakos Inc.'s (NASDAQ:ALLK) recent 11% drop adds to one-year losses - Simply Wall St
Eosinophilic Gastroenteritis Treatment Market 2032: EMA, - openPR
Barclays PLC Lowers Stock Position in Allakos Inc. (NASDAQ:ALLK) - Defense World
Allakos Inc. (NASDAQ:ALLK) Short Interest Down 15.7% in December - Defense World
Allakos Inc. (NASDAQ:ALLK) Short Interest Update - MarketBeat
Kuehn Law Encourages Investors of Allakos Inc. to Contact Law Firm - Kilgore News Herald
BNP Paribas Financial Markets Sells 103,658 Shares of Allakos Inc. (NASDAQ:ALLK) - Defense World
Contrasting GT Biopharma (NASDAQ:GTBP) and Allakos (NASDAQ:ALLK) - Defense World
Fmr LLC Increases Stock Holdings in Allakos Inc. (NASDAQ:ALLK) - Defense World
Fmr LLC Buys 685,623 Shares of Allakos Inc. (NASDAQ:ALLK) - MarketBeat
Allakos's SWOT analysis: AK006 potential drives stock outlook amid challenges - Investing.com Australia
1,750,000 Shares in Allakos Inc. (NASDAQ:ALLK) Bought by Point72 Asset Management L.P. - MarketBeat
3 US Penny Stocks Under $200M Market Cap To Watch - Yahoo Finance
Alexandria Inks 259 KSF Bay Area Life Science Lease - Commercial Property Executive
Allakos Reports Q3 2024 Results and Research Progress - TipRanks
All You Need to Know About Allakos (ALLK) Rating Upgrade to Buy - MSN
Allakos Inc. finalizes early lease termination, incurring $2.5 million in costs - Investing.com Canada
Allakos Inc. Alters Lease Agreement for Cost Savings - TipRanks
FMR LLC's Strategic Acquisition of Allakos Inc Shares - GuruFocus.com
Allakos's SWOT analysis: biotech firm's stock faces hurdles in CSU market - Investing.com
FY2024 EPS Estimates for Allakos Raised by Leerink Partnrs - MarketBeat
Allakos Runs Up Into A Near-Term Catalyst (NASDAQ:ALLK) - Seeking Alpha
Allakos Provides Business Update and Reports Third Quarter 2024 Financial Results - The Manila Times
10 Health Care Stocks Whale Activity In Today's SessionAllakos (NASDAQ:ALLK), Amgen (NASDAQ:AMGN) - Benzinga
Allakos perks up after early-stage data for lead asset - MSN
Urticaria Clinical Trial Pipeline Accelerates: 20+ Leading Companies Pioneering New Treatments | DelveInsight - GlobeNewswire Inc.
Urticaria Clinical Trial Pipeline Accelerates: 20+ Leading Companies Pioneering New Treatments | DelveInsight - GlobeNewswire
Allakos Inc. (NASDAQ:ALLK) Short Interest Down 17.1% in October - MarketBeat
3 US Penny Stocks With Market Caps Larger Than $50M - Simply Wall St
Allakos Insiders Miss 24% Gain After Offloading Stock - Simply Wall St
Vernal Keratoconjunctivitis Market Growth to Accelerate - openPR
The Manufacturers Life Insurance Company Sells 2,148 Shares of Innoviva, Inc. (NASDAQ:INVA) - Defense World
Short Interest in Custom Truck One Source, Inc. (NYSE:CTOS) Decreases By 5.5% - Defense World
Nasal Polyposis Market Size is Set for Rapid Growth as Innovative - openPR
Chronic Spontaneous Urticaria Market Forecasted to Surge - openPR
Jefferies downgrades Allakos Inc (ALLK) stock to a Hold - Knox Daily
Allakos Inc (ALLK)’s stock price range in the last year - US Post News
Investor’s Delight: Allakos Inc (ALLK) Closes Weak at 0.65, Down -1.14 - The Dwinnex
Allakos shares hold rating after trial update By Investing.com - Investing.com Australia
Piper Sandler maintains Overweight rating on Allakos shares By Investing.com - Investing.com Australia
Allakos Inc (ALLK) 財務データ
収益
当期純利益
現金流量
EPS
4.81%
大文字化:
|
ボリューム (24 時間):